Prognostic factors in idiopathic (primary) osteomyelofibrosis

Cancer

Volumn 80, Issue 4, 1997, Pages 708-719

  Kvasnicka, Hans Michael ^a   Thiele, Juergen ^a   Werden, Cordula ^a   Zankovich, Rudolf ^a   Diehl, Volker ^a   Fischer, Robert ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Idiopathic myelofibrosis; Life expectancy; Multivariate classification and regression free (CART) analysis; Prognostic parameters; Proportion of life loss; Relative survival

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOFIBROSIS; MYELOID METAPLASIA; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT;

ANALYSIS OF VARIANCE; BONE MARROW; FEMALE; HUMANS; MALE; MYELOFIBROSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030818725     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970815)80:4<708::AID-CNCR9>3.0.CO;2-I     Document Type: Article

References (43)

1. Varki A, Lottenberg R, Griffith R, Reinhard E. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine (Baltimore) 1983;62:353-71.
2. Geary CG. Clinical and hematological aspects of chronic myelofibrosis. In: Lewis SM, editor. Myelofibrosis, pathophysiology and clinical management. New York: Marcel Dekker, 1985:15-49.
3. Anger B, Seidler R, Haug U, Popp C, Heimpel H. Idiopathic myelofibrosis: retrospective study of 103 patients. Haematologica 1990;75:228-34.
4. Visani G, Finelli C, Castelli U, Petti MC, Ricci P, Vianelli N, et al. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol 1990;75:4-9.
5. Hasselbalch H. Idiopathic myelofibrosis - an update with particular reference to clinical aspects and prognosis. Int J Clin Lab Res 1993;23:124-38.
6. Rupoli S, Da Lio L, Sisti S, Campanati G, Salvi A, Brianzoni MF, et al. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann Hematol 1994;68:205-12.
7. Njoku OS, Lewis SM, Catovsky D, Gordon-Smith EC. Anaemia in myelofibrosis: its value in prognosis. Br J Haematol 1983;54:79-89.
8. Hasselbalch H. Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol 1990;34:291-300.
9. Pereira A, Cervantes F, Brugues R, Rozman C. Bone marrow histopathology in primary myelofibrosis: clinical and haematologic correlations and prognostic evaluation. Eur J Haematol 1990;44:94-8.
10. Manoharan A, Smart RC, Pitney WR. Prognostic factors in myelofibrosis. Pathology 1982;14:455-61.
11. Wolf BC, Neiman RS. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 1985;65:803-9.
12. Barosi G, Berzuini C, Liberator LN, Costa A, Polino G, Ascari E. A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 1988;70:397-401.
13. Thiele J, Zankovich R, Steinberg T, Fischer R, Diehl V, Agnogenic myeloid metaplasia (AMM) - correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients. Hematol Oncol 1989; 7:327-43.
14. Hasselbalch H, Jensen BA. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance. Eur J Haematol 1990;44:172-8.
15. Rozman C, Giralt M, Feliu R, Rubio D, Cortes MT. Life expectancy of patients with chronic nonleukemic myelo-proliferative disorders. Cancer 1991;67:2658-63.
16. Thiele J, Kvasnicka HM, Steinberg T, Zankovich R, Fischer R, Diehl V. Survival in primary (idiopathic) osteomyelofibrosis, so-called agnognic myeloid metaplasia. Leuk Lymphoma 1992;6:389-99.
17. Barosi G, Ambrosetti A, Buratti A, Finelli C, Liberato NL, Quaglini S, et al. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome predition. Leukemia 1993;7:200-6.
18. Thiele J, Windecker R, Kvasnicka HM, Titius BR, Zankovich R, Fischer R. Erythropoiesis in primary (idiopathic) osteomyelofibrosis: quantification, PCNA-reactivity, and prognostic impact. Am J Hematol 1994;46:36-42.
19. Dupriez B, Morel P, Demory JL, Laï JL, Simon M, Plantier I, at al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996;88:1013-8.
20. Gustavsson P, Holm J, Wahlin A, Norberg B. Staging of idiopathic myelofibrosis. Significance of haemoglobin value and reticulocyte count. Acta Med Scand 1985;218:487-91.
21. Hakama M, Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chronic Dis 1977;30:585-97.
22. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;32:933-42.
23. Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner B, Mahl G, et al. Chronic myeloproliferative disorders (CMPD). Pathol Res Pract 1984;1:131-86.
24. Thiele J, Hoeppner B, Zankovich R, Fischer R. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - correlations between laboratory and morphological features. Virchows Arch A Pathol Anat Histopathol 1989;415:191-202.
25. Georgii A, Vykoupil KF, Buhr T, Choritz H, Döhler U, Kaloutsi V, et al. Chronic myeloproliferative disorders in bone marrow biopsies. Pathol Res Pract 1990;186:3-27.
26. Lewis SM. Myelofibrosis: historical perspective. In: Lewis SM, editor. Myelofibrosis, pathophysiology and clinical management. New York: Marcel Dekker, 1985:1-13.
27. Iland JH, Laszlo J, Case DC, Murphy S, Reichert TA, Tso CY, et al. Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis. Am J Hematol 1987;25:191-201.
28. Burkhardt R. Bone marrow in megakaryocytic disorders. Hematol Oncol Clin North Am 1988;2:695-733.
29. Ellis JT, Peterson P, Geller SA, Rappaport H. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol 1986;23:144-55.
30. Pagliuca A, Layton DM, Manoharan A, Gordon S, Green PJ, Mufti GJ. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study in 10 cases. Br J Haematol 1989;71:499-504.
31. Verhoef GEG, De Wolf-Peeters C, Ferrant A, Deprez S, Meeus P, Stul M, et al. Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol 1991;63:235-41.
32. Maschek H, Georgii A, Kaloutsi V, Werner M, Bandecar K, Kressel MG, et al. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol 1992;48:208-14.
33. Schaefer HE. How to fix, decalcify and stain paraffin embedded bone marrow biopsies. In: Lennert K, Hübner K, editors. Pathology of the bone marrow. Stuttgart: Fischer, 1984:6-9.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-81.
35. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation for each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
36. Cox DR. Regression models and life tables (with discussion). J R Statist Soc B 1972;34:187-220.
37. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
38. Hakulinen T, Tenkanen L, Abeywickrama KH, Päivärinta L. Testing equality of relative survival patterns based on aggregated data. Biometrics 1987;43:313-25.
39. Breiman L, Friedman JH, Ohlsen RA, Stone CJ. Classification and regression trees. Belmont, CA: Wadsworth, 1984.
40. Gordon L, Ohlsen RA. Tree-structured survival analysis. Cancer Treat Rep 1985;69:1065-8.
41. Segal MR. Regression trees for censored data. Biometrics 1988;44:35-47.
42. Segal MR, Bloch DA. A comparison of estimated proportional hazard models and regression trees. Stat Med 1989;8:539-50.
43. Demory JL, Dupriez B, Fenaux P, Laï JL, Beuscart R, Jouet JP, et al. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood 1988;72:855-9.